PIPELINE & PRODUCTS
Pipeline & Products
Building a product-delivery capability matrix around our mRNA platform: approved products, core equipment, scalable manufacturing, and algorithmic systems.
PIPELINE
Pipeline
Filter
Prophylactic Vaccines
预防性疫苗
Code
Program
Regulatory Country
Discovery
Preclinical
IND/IIT
Phase I
Phase II
Phase III
Approved
RQ-3013
Chimeric COVID-19 mRNA Vaccine
China
Indonesia
RQ-3033
Variant-adapted COVID-19 mRNA Vaccine (XBB.1.5)
China (EUA)
Indonesia
RQ-3064
Variant-adapted COVID-19 mRNA Vaccine (JN.1)
China
RQ-3200
RSV mRNA Vaccine
China
USA
RQ-3400
Herpes Zoster (VZV) mRNA Vaccine
China
Immunotherapy
免疫治疗
Code
Program
Regulatory Country
Discovery
Preclinical
IND/IIT
Phase I
Phase II
Phase III
Approved
RQ-2010
Therapeutic HBV Vaccine
China
RQ-2026
In vivo CAR-T Therapy
China
RQ-2500
Personalized Cancer Vaccine
China
RQ-2400
EBV-associated Nasopharyngeal Carcinoma Immunotherapy
China
RQ-2700
HPV Immunotherapy
China
RQ-2060
TCE Tumor Therapy
China
PRODUCTS
Product Matrix
Approved products, core equipment, and algorithmic systems—forming a sustainable R&D → translation → delivery loop.
Approved Vaccine Product
Built on an engineered mRNA platform, enabling a reusable capability loop from molecular design and process development to industrial delivery.
Benchtop LNP System
A desktop LNP platform for R&D and process exploration—supporting rapid DoE, formulation screening, and small-scale scale-up validation.
Production-scale LNP System
A production equipment suite designed for scalable, consistent delivery—supporting robust scale-up from pilot to commercial manufacturing.
iTRUST Algorithm
Individualized True Neoantigen Selection for Tumors: prioritizes patient-specific true neoantigens to enable personalized therapeutic cancer vaccine design.
Floors 7–9, Building C7, Bay Valley Science and Technology Park, Yangpu District, Shanghai
Follow us
©2026 RNACure BioPharma. All rights reserved.